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1Abstract
This master’s dissertation concentrates on how epidemics occur, and how we can predict the likely
outcomes. We use mathematical models to analyse how different population groups interact, and
how certain parameters can be pivotal in accurately predicting epidemics. Throughout this dis-
sertation we will focus on work done in the book by Murray [12] and the paper by Kermack and
McKendrick [9]. We study the Human Immunodeficiency Virus (HIV), and discuss a population
model which predicts how the virus behaves in a homosexual population. Then we then formulate
a model of the biological make up of the disease. This enables us to evaluate the potential effects
drug therapy can have in reducing the evolution of HIV into AIDS, and in reducing the spread of
HIV within the population. We will evaluate how numerical approximations can provide an insight
into how an epidemic may develop when analytic solutions cannot be obtained. Computed approx-
imations will then be compared to explain the likely outcomes when an epidemic occurs.
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Chapter 1
The SIR model
1 Introduction to Epidemic Models
Epidemiological mathematical models allow us to predict how a disease will behave once it has been
introduced into a population. A suitable model will predict the evolution of the epidemic and enable
authorities to implement strategies to help curb the spread and ultimately eradicate the epidemic.
When creating an epidemic model, two main assumptions are made,
• Diseases do not occur at random.
• Diseases have preventative factors that can be identified within a population.
Before we can start to construct a model, it is first necessary to identify the key factors that affect
the model. Firstly, it is important to identify the population who is most at risk of disease, this
population may be restricted to certain age groups or sex’s. Secondly, we need to identify the
geographical spread of the disease; some diseases have outbreaks all over the world whilst others
are confined to isolated areas. For example, the Human Immunodeficiency Virus (HIV) has spread
to almost every country on earth.
Figure 1.1: HIV worldwide spread. [19]
However, as we can see from Figure 1.1, there are concentrated areas where the prevalence of HIV
exceeds 20%, in such areas the chances of an epidemic occurring is much greater than in areas with
3
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a lower prevalence. It is therefore important to try and establish why the disease is so prevalent
in areas such as southern Africa. We can do this by examining data on factors such as when does
the epidemic break out, for example it may be a seasonal problem or weather dependent. We may
also want to evaluate how the disease is transmitted, as this may provide reasons to why certain
area’s have a higher percentage of people infected with the disease. Finally, it is useful to establish
which, if any, measures have already been put in place to try and combat the spread of the disease.
This single factor alone may account for why certain countries have a really low prevalence, and
others do not. Measures such as ensuring all children have access to education, can be essential in
reducing the proportion of people who catch certain diseases, and in turn reducing the likelihood
of a epidemic.
For a model to be useful, it must have the ability to adapt to new situations, be transparent, so that
we can deduce how a change in a single variable may alter the overall behavior of the problem, and
last but not least, the model must be accurate when compared to the collected data. Sometimes
the creation of a model can be extremely difficult due to a lack of complete data to work with.
Without accurate data it is very hard to deduce parameter values which are essential for creating
an accurate model.
2 The SIR Model
When modeling a population of individuals we are interested in not only the size of the overall
population but the size of different population groups. As it is not feasible to attempt to model the
number of virus particles within the population, we instead categorise individuals into subgroups
depending on their infection status. In an SIR model individuals are categorised as either
• Susceptible, S, who have not been exposed to the pathogen.
• Infected, I, who have been colonised by the pathogen.
• Recovered, R, who have fought of the infection and recovered or died due to the infection.
When there is the absence of demography within a population the standard SIR model is described
as follows [9],
dS
dt
= −rSI, (1.1)
dI
dt
= rSI − aI, (1.2)
dR
dt
= aI, (1.3)
where a represents the removal rate of invectives, whilst r is the infection rate. The removal rate
of invectives, is the product of the contact rate of susceptibles and invectives, and the transmission
probability. Since the population has no demography it’s clear that,
S(t) + I(t) +R(t) = N, (1.4)
where N represents the total population. The relationship between the different populations de-
pends on parameters a and r.
CHAPTER 1. THE SIR MODEL 5
0 5 10 15 20 25 30
Time
0
10
20
30
40
50
60
70
80
90
100
S
I
R
Figure 1.2: The relationship between the different population groups in the SIR model with a = 0.1,
r = 0.6, S(0) = 99,I(0) = 1 and R(0) = 0.
Figure 1.2 illustrates that, when initial conditions are known and the parameters are estimated, the
SIR model can determine whether or not an epidemic will occur. In the example used to construct
Figure 1.2 the epidemic occurs around week 12. To deduce whether an epidemic may occur within
a population, the basic reproduction number B0 is a useful parameter. B0 is the average number of
secondary cases of infection arising from an average primary case within a susceptible population,
hence it can be defined as B0 =
Sr
a
. In an entirely susceptible population S = 1, hence,
• A primary infected individual spends on average 1
a
units of time infectious.
• Per unit of time the primary infected individual contacts a× S = a× 1 individuals.
• Per unit of time these contacts result in r × a× 1 secondary infections.
• Over the period of time the primary infected individual is infected, there are resulting,
r × a× 1× 1
a
=
r
a
secondary infections.
• Hence,
B0 =
r
a
.
Kermack and McKendrick’s report on the mathematical theory of epidemics shows that if the
proportion of Susceptibles is reduced below
1
B0
then the infection dies out, see [9]. Hence, an
epidemic occurs when the amount of new cases arising per period of time is greater than the
number of underlying cases expected in the same period of time. We can now show how we deduce
this relationship, given the following initial conditions
S(0) = S0 > 0, I(0) = I0 > 0, R(0) = 0. (1.5)
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Substituting the initial conditions into equation (1.2) to get,[
dI
dt
]
t=0
= I0(rS0 − a). (1.6)
Then by letting p =
a
r
, the change in the infective population at t = 0 see (1.2), is greater than
zero if S0 > p, and less than zero if S0 < p. Indeed,
[
dI
dt
]
t=0
= I0(rS0 − a)

> 0
= 0
< 0
if S0 =

> p
= p
< p
.
As (1.1) shows S is a decreasing population for all t, which implies that S0 ≥ S. Therefore, we can
see that if S0 <
a
r
then S <
a
r
for all t > 0, then we can deduce the following
dI
dt
= I(rS − a) ≤ 0, for all t ≥ 0. (1.7)
Moreover, let φ defined as
φ(t) = I(t)e−(rS0−a)t, t ≥ 0. (1.8)
In view of (1.7) and by using the fact that S < S0 <
a
r
we can see that
φ′(t) =
(
dI
dt
− (rS0 − a)I
)
e−(rS0−a)t ≤ 0. (1.9)
Thus, φ is decreasing, that is φ(t) ≤ φ(0),∀t > 0. We conclude that
I(t) ≤ I0e(rS0−a)t (1.10)
Since limt→∞ e(rS0−a)t = 0, we obtain that limt→∞ I(t) = 0, therefore the infection will die out, and
thus an epidemic will not occur. On the other hand if S0 <
a
r
then I(t) does initially increase and
so an epidemic will occur. From (1.7) we can see that if S0 = p then then
[
dI
dt
]
t=0
= 0 hence the
infective population is stationary. Eliminating time t from (1.1) and (1.2) to obtain,
dI
dS
=
rSI − aI
−rSI = −1 +
aI
rSI
= −1 + a
rS
= −1 + p
S
i.e.,
dI =
(
−1 + p
S
)
dS.
We can now integrate both sides, ∫
dI =
∫ (
−1 + p
S
)
dS
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to get
I(t) = −S(t) + p ln(S(t)) + c, (1.11)
where c is a constant. By applying the initial conditions to (1.11) we obtain,
c = I0 + S0 − p ln(S0). (1.12)
According to (1.4) we can conclude that there are only two independent equations in the SIR model,
namely the equations(1.1) and (1.2). From equation (1.4) we can also see that,
S + I ≤ N,
therefore we can deduce the following conditions,
S(t) >
p
S0
⇒ dI
dt
> 0
likewise,
S(t) <
p
S0
⇒ dI
dt
< 0.
Since B0 is derived as,
B0 =
S0
p
.
If the basic reproductive rate is greater than one, then an epidemic occurs.
S
I
0 N
N
P
S + I = N
dI
dt
< 0
dI
dt
> 0
Figure 1.3: Phase Plane diagram showing the relationship between Susceptible and Infective classes
in the SIR model.
Using the relationships derived, and the initial conditions shown in equation (1.5), then the phase
plane diagram shown in Figure 1.3 can be constructed. To establish the severity of an epidemic
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we need to calculate the maximum number of invectives, Imax. We can see from Figure 1.3 and
equation (1.7) that I achieves its maximum value at S = p where
dI
dt
= 0. In view of (1.11),
Imax = −p+ p ln(p) + c,
thus, using (1.12) we can derive,
Imax = −p+ p ln(p) + I0 + S0 − p ln(S0)
= I0 + S0 − p+ p ln
(
p
s0
)
= N − p+ p ln
(
p
s0
)
.
Hence, I → 0 as t → ∞. It’s also clear from the phase plane diagram shown in Figure 1.3 that
dS
dt
< 0 for S 6= 0 and I 6= 0. Next, by eliminating time t from (1.1) and (1.3), we get
dS
dR
= −r
a
S = −S
p
. (1.13)
Separate the variables and integrate both sides to get
ln(S) = −R
p
+ c,
from which we can conclude that
S = Ce−
R
p , (1.14)
with C being any real constant. By using the initial condition (1.5) we can deduce that,
C = S0.
We can thus conclude that the solution of (1.13) is given by
S = S0e
−R
p ; (1.15)
hence, we can now use the following relation
S = S0e
−R
p ≥ S0e−
N
p > 0,
to show that
0 < S(∞)
and to conclude that
0 < S(∞) ≤ N.
Moreover from Figure 1.3 we see that the inequality is actually 0 < S(∞) ≤ p and I(∞) = 0 implies
that,
R(∞) = N − S(∞)
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hence,
S(∞) = S0e−
R(∞)
p = S0e
−N−S(∞)
p .
Therefore, as 0 < S(∞) < p, S(∞) is the positive root of the transcendental equation,
S0e
−N−z
p = Z, 0 < Z < p. (1.16)
The total number who become infected is shown as the Itotal,
Itotal = I0 + S0 − S(∞). (1.17)
It is apparent from equation (1.16) that S(∞) is a solution of Z. We can deduce that I(t) → 0
where S(t) → S(∞) > 0, therefore the disease does not die out because of a lack of susceptibles,
but due to a lack of infectives. To apply this model to actual epidemic situations we need to know
the amount removed per unit time, dR/dt. From equation (1.3),(1.4) and (1.15) we can get an
equation with only one parameter R,
dR
dt
= aI = a(N −R− S) = a(N −R− S0e−
R
p ), R(0) = 0. (1.18)
Kermack and McKendrick(1927) proposed using Taylor expansion around zero to evaluate the e−
R
p
term [9]. Using this formula we can evaluate e−
R
p around the point R = 0,
e−
R
p = 1− 1
p
R +
1
2p2
R2 − 1
6p3
R3 + . . .
≈ 1− 1
p
R +
1
2p2
R2.
Therefore,
−S0e−
R
p ≈ −S0 + S0
p
R− S0
2p2
R2.
Thus, we can re-write equation (1.18) as
dR
dt
= a
[
N − S0 +
(
S0
p
− 1
)
R− S0R
2
2p2
]
. (1.19)
Factorising the right hand side of equation (1.19) will enable us to integrate this equation in order
to deduce the solution. We will now find the roots of equation (1.19) as follows,
dR
dt
= a
[
N − S0 +
(
S0
p
− 1
)
R− S0R
2
2p2
]
(1.20)
Since
(
S0
p
− 1
)2
+ 4(N −S0)
(
S0
2p2
)
> 0, the quadratic equation on the right hand side of (1.20) has
two real roots given by
R1,2 =
−
(
S0
p
− 1
)
±
√(
S0
p
− 1
)2
+ 4(N − S0)
(
S0
2p2
)
−S0
p2
=
−
(
S0
p
− 1
)
± α
−S0
p2
,
(1.21)
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with
α =
√(
S0
p
− 1
)2
+ 2(N − S0)
(
S0
p2
)
.
Therefore we have the following,
R1 = p− p
2
S0
− p
2α
S0
, and R2 = p− p
2
S0
+
p2α
S0
.
Since α >
S0
p
− 1, (1.21) implies that R1 < 0 and R2 > 0. Thus,
dR
dt
= a
[
N − S0 +
(
S0
p
− 1
)
R− S0R
2
2p2
]
= a
−S0
2p2
(R−R1)(R−R2).
We can solve the last equation by applying the separation of variables technique, namely∫
dR
(R−R1)(R−R2) =
∫ −S0a
2p2
dt. (1.22)
We can easily see that,
2αp2
S0
dR
(R−R1)(R−R2) =
[
1
R−R2 −
1
R−R1
]
dR.
Therefore, ∫
1
R−R2 −
∫
1
R−R1 = ln |R−R2| − ln |R−R1|
= ln
∣∣∣∣R−R2R−R1
∣∣∣∣ .
Which implies,
ln
∣∣∣∣R−R2R−R1
∣∣∣∣ = −αa ∫ dt
= −αat− αac
where c is any constant. Using the initial conditions R(0) = 0 we get
ln
∣∣∣∣−R2−R1
∣∣∣∣ = −αac.
Note that R1 < 0 and R2 > 0, therefore we obtain
R2 = −R1e−αac.
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Substituting the values for R1 and R2 into the above equation,
p− p
2
S0
+
αp2
S0
= −
(
p− p
2
S0
− αp
2
S0
)
e−αac,
Collecting like terms will enable us to simplify further,
p
(
1 + e−αac
)− p2
S0
(
1 + e−αac
)
+
αp2
S0
(
1− e−αac) = 0. (1.23)
Dividing (1.23) by (1 + e−αac) to get that
p
(
1− p
S0
)[
1 + e−αac
1− e−αac
]
= −αp
2
S0
.
Using trigonometric identities enables us to replace the exponential function,
p
(
1− p
S0
)[
tanh
(−αac
2
)]−1
=
αp2
S0
,
which implies [
tanh
(−αac
2
)]−1
=
αp
S0
(
1− p
S0
) .
Therefore,
tanh
(−αac
2
)
=
(
S0
p
− 1
)
1
α
,
Which implies the following
−αac = tanh−1

(
S0
p
− 1
)
α
 = 2φ.
Now that we have calculated the constant, we can evaluate an expression for R(t) which only
depends on t,
ln
∣∣∣∣R−R2R−R1
∣∣∣∣ = −αat+ 2φ
which implies
ln
∣∣∣∣R−R1R−R2
∣∣∣∣ = αat− 2φ.
Thus, ∣∣∣∣R−R1R−R2
∣∣∣∣ = eαat−2φ.
By calculating the second derivative we can determine the type of equilibrium point R1 and R2 are,
dR2
dt2
= a
[
S0
p
− 1− S0R
p2
]
.
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At R1 we have,
dR2
dt2
= a
[
S0
p
− 1− S0
p2
(
p− p
2
S0
− p
2α
S0
)]
= aα > 0.
As a, α > 0, R1 is a minimum point. For R2 we get
dR2
dt2
= a
[
S0
p
− 1− S0
p2
(
p− p
2
S0
+
p2α
S0
)]
= −aα < 0,
which implies R2 is a maximum point. Thus, (R − R1) > 0 since R1 < R with R1 < 0. Whereas
(R−R2) < 0 as R < R2 with R2 > 0. Therefore we get that
R−R1 = (R−R2)
(−eαat−2φ) . (1.24)
Substituting the values for R1 and R2 into (1.24) will enable us to derive an expression for R(t),
R−
(
p− p
2
S0
+
αp2
S0
)
=
(
R−
(
p− p
2
S0
− αp
2
S0
))(−eαat−2φ) ,
collecting like terms together will further enable us to simplify the expression,
R
(
1 + eαat−2φ
)− p (1 + eαat−2φ)+ p2
s0
(
1 + eαat−2φ
)− αp2
S0
(
1− eαat−2φ) = 0,
hence,
R(t) = p
(
1− p
S0
)
+
αp2
S0
(
1− eαat−2φ
1 + eαat−2φ
)
=
p2
S0
[(
S0
p
− 1
)
+ α tanh
(
αat
2
− φ
)]
.
(1.25)
Therefore, the removal rate is given by,
dR
dt
=
aα2p2
2S0
sech2
(
αat
2
− φ
)
. (1.26)
The removal rate formula (1.26) has only three parameters, namely aα
2p2
2S0
, αa and φ. This
simplifies the application of the model to real life data, and can means the removal rate can be
quickly approximated.
3 The Bombay plague Epidemic
Kermack and McKendrick used parameters values which accurately represented the data collected
in 1906, this enables the model to be a good fit when compared with the real figures [9]. Hence
they came up with the following adapted removal rate.
dR
dt
= 890sech2(0.2t− 3.4) (1.27)
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Since most people who got the plague died, Figure 1.4 is the approximate number of deaths per
week. It shows that we would expect a peak at around 17 weeks, where 900 people would die in a
single week. In comparison to the overall population size, Kermack and McKendrick concluded the
epidemic was not too severe [9].
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900
 : dR/dt
Figure 1.4: Graph of equation (1.27) over a 30 week time period.
During the Bombay plague epidemic in the spring of 1906, the incubation period was around 10
days. Death from the plague would occur around 4 days after the incubation period. Hence we
can approximate that it took about 2 weeks for people to die from the plague after being infected.
Hence the removal rate of invectives is 0.5 per week. Therefore if a = 0.5 it is possible to work out
the other parameters. Using the values in equation (1.27) and comparing them to the parameters
in equation (1.26) we deduce that α = 0.8, hence
tanh−1
(
S0
p
− 1
α
)
= 3.4
therefore,
S0
p
− 1
α
= tanh(3.4)
which implies that,
S0 = 1.7982199p. (1.28)
Comparing the other values gives,
aα2p2
2S0
= 890.
We can simplify this equation by substituting in our value for α, hence
p2
S0
= 10002.59819,
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using (1.28) we can get a value for p of 10002.59843. Therefore S0 = 17986.87154. These values
will be extremely important when we construct a numerical approximation of the model.
Chapter 2
Mathematical Modeling of HIV
1 Introduction to Human Immunodeficiency Virus (HIV)
Sexually transmitted diseases (STDs), such as Chlamydia, Gonorrhea and HIV, differ from many
other infectious diseases due to the method of transmission. The most common mode of transmis-
sion is through sexual contact. Public Health England state that 95% of those who where infected
with HIV in England during 2013 acquired the disease through sexual contact.
Before we discuss the mathematical modelling of STDs such as HIV, it is first necessary to deduce
the factors that affect the spread of the disease and the ways in which it is transmitted. Firstly
we need to consider the interactions between different susceptibles. In a completely heterosexual
population, it is a criss cross disease as there are two interacting groups, males and females, where
each group is the disease host for the other. However, in real populations there exists homosexual,
bisexual and heterosexual populations.
In 2013 the British Office of National statistics (ONS) conducted the integrated household survey
and found the following statistics [13]:
• 1.2 per cent of adults identified themselves as gay or lesbian which is approximately 545,000
adults.
• 0.5 per cent of adults identified themselves as bisexual which equates to approximately 220,000
adults.
• 3.9 per cent of adults said they they didn’t know or refused to give an answer on there
sexuality.
Of the statistics gathered by the ONS, one of the most surprising is that men were more likely
than women to consider themselves as gay or lesbian. Indeed, 1.6 per cent of adult males identified
themselves as gay compared with just 0.8 per cent of adult females.
When HIV antibodies are detected in the patient, the patient is categorised as HIV positive, these
antibodies can be produced anytime from a week to several months after the infection. Unless there
is an intervention with drug therapy the patient will enter a latent period before exhibiting the
15
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end-stage disease which is classified as acquired immunodeficiency syndrome (AIDS). According to
the World Health Organization it can take up to 10 years for HIV to become AIDS, however in the
majority of cases it takes a significantly shorter period of time. This varying incubation period is a
major issue when it comes to understanding and controlling the spread of the disease.
The rise in the quantity of people who have STD’s is a major worry for not only the world health
organisations but also for governments around the world. Certain characteristics of STD’s such as
only the sexually active population can be infected may appear to make any epidemic outbreaks
easier to control. However many social problems such as the stigma attached to HIV means that
the virus is not openly discussed within society and hence gathering any accurate data is extremely
difficult. A report written by UNAIDS on the global epidemic of HIV and AIDS estimates that 27
million people are HIV positive but are unaware that they contain the virus.[20]
Data which is available shows that the majority of people who already have HIV and AIDS live
in some of the poorest countries in the world. Recent estimates suggest that as many as 70% of
deaths due to AIDS occur in Africa. The report by UNAIDS [20] also highlights how the inabil-
ity to control the spread of AIDS is an index of the substandard governance, bad education and
a reluctance to accelerate the development of underdeveloped countries. The decline of real per
capita incomes in the 30 poorest economies since 1980 is just one example of the failure of the world
organisations to help improve the lives of millions of people. Unless developed countries open their
markets to less developed countries and begin to try and encourage globalisation, it is impossible
for the poorest countries to make significant strides in tackling poverty. Reports such as the one by
UNAIDs have highlighted that it is not feasible to try and just tackle each disease independently.
To be successful it is necessary to tackle the more general issues such as poverty, income inequality
and refugee movement, all of which affect the spread of HIV. Tackling the wider issues will mean
more developed countries will posses a greater ability to not only tackle the spread of STD’s such
HIV, but to educate more people on how to avoid catching such diseases, and where to go if they
think they have the symptoms.
If we imagine a population in which everyone is infected with HIV at t = 0, and let z(t) denote
the proportion of people who have AIDS, v(t) as the proportion who are HIV positive but do not
yet have AIDS and k(t) be the rate of conversion from HIV positive to aids, then we have the
following model,
dv
dt
= −k(t)v,
dz
dt
= k(t)v,
(2.1)
where
v(0) = 1, z(0) = 0, v + z = 1.
This simplified model makes the assumption that every person who is HIV positive develops AIDS,
which is not always the case. From biological research it is known that the immune system’s response
to diseases becomes increasingly impaired the longer the period of time since infection. Hence the
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conversion rate to AIDS is an increasing function,
k(t) = bt,
where b > 0 is constant. Thus, the first equation of (2.1) can be written in the form
dv
dt
= −btv, (2.2)
which implies
ln(v) =
−bt2
2
+ c1,
with c1 being any real constant. We can easily see that
v(t) = C1e
(
−bt2
2
)
,
by using the initial condition v(0) = 1, we get that
v(t) = e
(
−bt2
2
)
.
Since v + z = 1, we can deduce that
z(t) = 1− e
(
−bt2
2
)
.
However this model is very simple and has unrealistic assumptions such as everyone is infected with
HIV at t = 0. Therefore in this next section we will use a more realistic model.
2 Modeling an Aids Epidemic in a Homosexual Population
If we now look at the development of an aids epidemic in a homosexual population where X(t),
Y (t), A(t) and Z(t) denote the amount of susceptible’s, infectious males, AIDS patients and the
amount of seropositives who are non-infectious, we can make a more realistic model by making the
following realistic assumptions,
• We let B represent the birth rate entering the susceptible class.
• We assume that individuals in all classes can die naturally and we denote this natural death
rate as µ.
• We also let the rate of transmission from susceptible to infectious be λc, where λ represents
the probability of being infected with HIV from a random individual, and c represents the
number of sexual partners an individual has had.
• We denote the proportion of infectives who develop AIDS as pv, where p is the proportion of
HIV positive individuals who are infectious.
• Hence, the proportion of infectives who don’t develop the disease and become non-infectious
is (1− p)v.
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• Finally we let the death rate due to aids be denoted by d.
These assumptions enable us to create Figure 2.1 representing the flow of individuals depending on
their infectious status.
Natural Death
Natural Death
B
λc
µ
µ
(1− p)vpv
d
µ µ
Susceptible X
Infectious Y
Aids A Seropositive/
Non Infectious
Z Natural DeathNatural Death
Disease induced Death
Figure 2.1: Flow chart showing the different classes and the parameters which effect the movement
of individuals from one class to another.
We can thus arrive at the following system of ordinary differential equations which models HIV
disease
dX
dt
= B − µX − λcX, λ = βY
N
(2.3)
dY
dt
= λcX − (v + µ)Y, (2.4)
dA
dt
= pvY − (d+ µ)A, (2.5)
dZ
dt
= (1− p)vY − µZ, (2.6)
see [12] for more details. Here, β is the transmission probability and the total population size can
be expressed as,
N(t) = X(t) + Y (t) + Z(t) + A(t). (2.7)
From these parameters shown in the model above, we are able to deduce that the average incubation
time of the disease is 1/v. Thus, the basic reproduction ratio can be defined as,
R0 ≈ βc
v
. (2.8)
The epidemic begins when R0 > 1, where the population model will evolve to a steady state as
shown below. Steady states occur when,
B − µX − λcX = 0, (2.9)
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λcX − (v + µ)Y = 0, (2.10)
pvY − (d+ µ)A = 0, (2.11)
(1− p)vY − µZ = 0. (2.12)
By adding (2.9) and (2.10) we obtain
B − µX − (v + µ)Y = 0,
from which we can conclude that
Y =
B − µX
v + µ
. (2.13)
The re-arranging of (2.9) produces a second equation for Y, that is
B = X(µ+ λc)
= X(µ+
βcY
N
),
which implies
Y =
NB
βcX
− µN
βc
. (2.14)
In view of (2.13) and (2.14) we have that
NB
βcX
− µN
βc
=
B − µX
v + µ
,
from which we get
BX − µX2 + (v + µ)µNX
βc
=
(v + µ)NB
βc
,
i.e.,
X2 −X
(
(v + µ)µN
βc
+
B
µ
)
+
(v + µ)NB
βµc
= 0. (2.15)
Therefore
X =
(
(v+µ)N
βc
+ B
µ
)
±
√(
(v+µ)N
βc
+ B
µ
)2
− 4 (v+µ)NB
βµc
2
(2.16)
The value inside the square root in (2.16) can be simplified as follows(
(v + µ)N
βc
+
B
µ
)2
− 4(v + µ)NB
βµc
=
(
N2(v + µ)2
β2c2
+
B2
µ2
+ 2
NB(v + µ)
βµc
)
− 4(v + µ)NB
βµc
=
(
N2(v + µ)2
β2c2
+
B2
µ2
− 2NB(v + µ)
βµc
)
=
(
N(v + µ)
βc
− B
µ
)2
.
(2.17)
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From which we can conclude that (2.16) has two real roots given by
X =
(
(v+µ)N
βc
+ B
µ
)
±
∣∣∣N(v+µ)βc − Bµ ∣∣∣
2
.
We can easily see that for any real numbers x and y there holds x+ y± |x− y| = 2x or 2y. We can
thus deduce that the last equation has the following two solutions
X∗ =
B
µ
and X∗ =
(v + µ)N
βc
. (2.18)
Note that the first solution X = B
µ
, corresponds to the steady state in the absence of infection. We
are interested in what happens when the disease is present, therefore we will concentrate on the
second solution for X. Adding equations (2.9)-(2.12) and using (2.7) to get,
B − µN − dA = 0,
namely
A∗ =
B − µN
d
. (2.19)
According to (2.11) we have
Y =
(d+ µ)A
pv
,
which in view of (2.19) gives
Y ∗ =
(d+ µ)(B − µN)
pvd
. (2.20)
We can now use (2.12) to get
Z =
(1− p)vY
µ
, (2.21)
from which and (2.20) we can conclude that
Z∗ =
(1− p)(d+ µ)(B − µN)
pdµ
. (2.22)
In view of (2.7), (2.18), (2.19), (2.20) and (2.22) we obtain
N∗ =
Bβ[µ(v + d+ µ) + vd(1− p)]
[v + µ][β(d+ µ)− pv]
Hence, the infected steady state occurs at,
X∗ =
(v + µ)N
βc
, Y ∗ =
(d+ µ)(B − µN∗)
pvd
,
Z∗ =
(1− p)(d+ µ)(B − µN∗)
pdµ
, A∗ =
B − µN∗
d
,
N∗ =
Bβ[µ(v + d+ µ) + vd(1− p)]
[v + µ][β(d+ µ)− pv] .
(2.23)
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To calculate the stability of the infected steady states we first need to calculate the Jacobian J
matrix of the system of equations (2.3)-(2.6) at the critical point (X∗, Y ∗, A∗, Z∗). We have that
J(X∗, Y ∗, A∗, Z∗) =

−µ− λc −cβX∗
N∗ 0 0
λc cβX
∗
N∗ − (v + µ) 0 0
0 pv −(d+ µ) 0
0 (1− p)v 0 −µ
 .
Next we evaluate the eigenvalues δ, of matrix J, which satisfy the equation
|J − δI| = 0 ⇒ 0 =
∣∣∣∣∣∣∣∣
(−µ− λc)− δ −cβX∗
N∗ 0 0
λc cβX
∗
N∗ − (v + µ)− δ 0 0
0 pv −(d+ µ)− δ 0
0 (1− p)v 0 −µ− δ
∣∣∣∣∣∣∣∣ .
We can deduce that the first eigenvalue is δ1 = −µ and the other eigenvalues must satisfy
0 =
∣∣∣∣∣∣
(−µ− λc)− δ −cβX∗
N∗ 0
λc cβX
∗
N∗ − (v + µ)− δ 0
0 pv −(d+ µ)− δ
∣∣∣∣∣∣ , (2.24)
from which we can conclude that
(−(d+ µ)− δ)
[
((−µ− λc)− δ)
(
cβX∗
N∗
− (v + µ)− δ
)
− (λc)
(−cβX∗
N∗
)]
= 0.
Hence, we can deduce that the second eigenvalue is δ2 = −(d+ µ). Moreover,
0 = ((−µ− λc)− δ)
(
cβX∗
N∗
− (v + µ)− δ
)
− (λc)
(−cβX∗
N∗
)
= δ2 +
(
(v + µ) + (µ+ λc)− cβX
∗
N∗
)
δ
+
[
(−µ− λc)
(
cβX∗
N∗
− (v + µ)
)
+ (λc)
(
cβX∗
N∗
)] (2.25)
According to (2.18) the constant term in the above equation can be simplified as follows
(−µ− λc)
(
cβX∗
N∗
− (v + µ)
)
+ (λc)
(
cβX∗
N∗
)
= −(µ+ λc)(v + µ) + (v + µ)(µ+ λc) + λc(v + µ)
= λc(v + µ)
Hence, (2.25) becomes,
δ2 + ((v + µ) + (µ+ λc)− (v + µ))δ + λc(v + µ) = 0
i.e,
δ2 + (µ+ λc)δ + λc(v + µ) = 0.
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We can apply the quadratic formula to find the third and fourth eigenvalues, namely
δ3,4 =
−(µ+ λc)±√(µ+ λc)2 − 4λc(v + µ)
2
.
To evaluate the stability of the infected steady state we do not require the exact solution for each
eigenvalue, instead we just need to obtain whether or not they are positive or negative. From
inspection it is apparent that δ1 and δ2 are both negative since the parameters d and µ are both
positive. If δ3 and δ4 are both negative then the steady state is stable.If δ3 > 0 then
δ3 =
−(µ+ λc) +√(µ+ λc)2 − 4λc(v + µ)
2
> 0, (2.26)
which implies that
(µ+ λc) <
√
(µ+ λc)2 − 4λc(v + µ).
Moreover,
(µ+ λc)2 − (µ+ λc)2 < −4λc(v + µ),
which gives,
0 < −λc(v + µ). (2.27)
The inequality (2.27) is not true since all four parameters λ,c,v and µ are positive, therefore δ3 < 0.
Similarly for δ4 to be positive,
δ4 =
−(µ+ λc)−√(µ+ λc)2 − 4λc(v + µ)
2
> 0,
then
(µ+ λc) < −
√
(µ+ λc)2 − 4λc(v + µ),
i.e.,
(µ+ λc)2 − (µ+ λc)2 < −4λc(v + µ),
from which we can conclude that
0 < −λc(v + µ).
This is the same condition, and cannot be true since all the parameters involved are positive.
Therefore δ4 is also negative, thus the infected steady state is stable. To deduce the type of the
infected steady state, we need to determine whether or not the eigenvalues are real or imaginary.
Therefore we will evaluate the sign of the square root in (2.26), If steady state is complex then we
get that,
(µ+ λc)2 − 4λc(v + µ) < 0. (2.28)
If (2.28) is true then the infected steady state is complex, however it will still be stable as the real
part of the eigenvalues is still negative. Earlier we deduced a value for R0 in equation (2.8). During
the early stages in an epidemic, almost every individual is in the Susceptible class, where X ≈ N ,
hence
dY
dt
≈ (βc− v − µ)Y
where
R0 ≈ βc
v
⇒ dY
dt
≈ v(R0 − 1)Y (2.29)
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This relation exists since the average life expectancy of a susceptible individual is a lot longer than
the average incubation time from the point of infection to the acquisition of the disease, therefore
v  µ. We will now solve equation (2.29) to obtain a solution for Y (t),
dY
dt
= v(R0 − 1)Y.
Separating the variables will enable us to integrate both sides of the equation
⇒
∫
1
Y
dY =
∫
v(R0 − 1)dt
from which we can conclude that
⇒ ln(Y ) = v(R0 − 1)t+ c2
where c2 is a constant. Therefore,
Y (t) = Y (0)ert (2.30)
where r = v(R0 − 1). It is now possible to calculate the doubling time td for the infectious males
class, when an epidemic exists the doubling time occurs when y(td) = 2Y (0). Therefore we can see
that from equation (2.30),
Y (td) = Y (0)e
rtd
hence
2Y (0) = Y (0)ertd
from which we can conclude the doubling time is
td =
ln(2)
v(R0 − 1) (2.31)
From equation (2.31) we can see that as R0 increases the doubling time of the epidemic shortens.
Substituting our solution for Y(t) into our equation for the population of AIDS patients (2.5), we
get,
dA
dt
= pvY (0)ert − (d+ µ)A (2.32)
using an integrating factor we can evaluate the solution of equation (2.32),
dA
dt
+ (d+ µ)A = pvY (0)ert
if we implement an integrating factor s(t), where s(t) = e
∫
(d+µ)dt = e(d+µ)t,then
e(d+µ)t
dA
dt
+ e(d+µ)t(d+ µ)A = pvY (0)erte(d+µ)t
which implies that
d
dt
(e(d+µ)tA) = pvY (0)ert+(d+µ)t
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we can now integrate both sides∫
d
dt
(e(d+µ)tA)dt =
∫
pvY (0)e(r+d+µ)tdt
which gives
e(d+µ)tA = pvY (0)
e(r+d+µ)t
r + d+ µ
+ c3
where c3 is any real constant. Therefore
A = pvY (0)
ert
r + d+ µ
+ c3e
−(d+µ)t
At the beginning of the epidemic there exists no aids patients as there is a reasonable incubation
period before HIV patients can develop aids, which implies A(0) = 0, hence
0 = pvY (0)
er(0)
r + d+ µ
+ c3e
−(d+µ)(0)
= pvY (0)
1
r + d+ µ
+ c3
we can now evaluate c3,
c3 = −pvY (0) 1
r + d+ µ
therefore we can write A(t) as,
A(t) = pvY (0)
ert
r + d+ µ
− pvY (0) 1
r + d+ µ
e−(d+µ)t
= pvY (0)
ert − e−(d+µ)t
r + d+ µ
.
(2.33)
Anderson [2] wrote a paper on transmission dynamics of HIV and used data collected by Peterman
[15] which focused on the spread and distribution of HIV in several different populations. The
report written by Anderson highlighted the key figures from the data collected by Peterman such
as the rate r, and the doubling time td. Some of the figures are shown in the table 2.1.
Country Period Rate (r/yr) Doubling Time td
USA 1981-1985 0.9 9.2
England 1982-1985 1.27 6.6
Italy 1983-1985 1.66 5
Switzerland 1983-1985 0.84 9.9
Sweden 1983-1985 1.04 8
Table 2.1: Doubling time td from HIV in the early stages of an epidemic
If we look at the data above it is clear that the doubling time varies quite a lot depending on which
country we are investigating. Using the data from 6875 homosexual and bisexual men who had
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attended a clinic over a 5 year period from 1978 to 1985 in America, we can calculate accurate
values for the parameters in equation (2.33). They calculated r = 0.88yr−1,R0 ≈ 5.15,d+ µ ≈ d =
1− 1.33yr−1,p = 10%− 30%,v ≈ 0.22yr−1 and c = 2− 6 partners a month. If we substitute these
into equation (2.31) we can estimate the doubling time for the HIV positive class of individuals,
td =
ln(2)
0.22(5.15− 1)
td = 0.7592years
(2.34)
The doubling time for the aids class is approximately 9 months. This figure is similar to the data
for the USA as whole shown in Table 2.1. We can see from the calculations that the doubling
time in dependent onR0, The larger R0 is the shorter the doubling time for the HIV positive
class. This relationship is to be expected if the epidemic is very severe, as there will be a greater
number of secondary infections from an average primary case due to an increase in the transmission
probability or the contact rate. Hence doubling time will be a lot shorter. If we analyse some of
the data displayed in the report by Anderson [2] in more detail we can see from table 2.2 that the
doubling time of aids incidence is greater in homosexual/bisexual men than it is in Heterosexual
contacts in the USA.
Group Doubling Time td Cases (1986) % of Total
Homosexual/Bisexual men, IV Drug Abusers 9.5 599 6.9
Homosexual/Bisexual men, non-IV Drug Abusers 9.1 5009 65.4
IV Drug Abusers 8.25 1429 16.5
Heterosexual Contacts 7.85 100 1.1
Table 2.2: Doubling time td in aids incidence by risk group in the early stages of an epidemic
In this chapter we have established that within the HIV model, there exists an infected steady state.
Therefore it is vitally important to understand the biological makeup of HIV, and to establish if
there exists some treatment which will eradicate the virus. This is what we will now focus on in
the next chapter.
Chapter 3
Treatment for HIV and Aids
1 Biological Makeup of HIV
Unlike many other retroviruses, HIV uses the mRNA of the invaded cell to synthesise its own RNA.
There are two main known varieties of HIV, the most common of which is HIV-1. Whilst most
viruses are destroyed by the immune system, HIV is only temporally halted by it and so is never
destroyed. Although HIV is one of the most studied viruses, some of its characteristics are not
fully understood, such as the reason for the sudden drop in T-cell count after the virus has infected
the host cells. The body usually replenishes the amount of T-cells at a quicker rate than HIV can
kill them. The normal level of T-cell count in a uninfected person is around 1000/µL, a patient
is diagnosed with aids when the level drops below 200/µL. CD4-T-cells are vital in the functions
of the immune system, HIV mainly infects CD4-T-cells called lymphocytes, these are a type of
white blood cell.“HIV attacks particular lymphocytes called T4 helper lymphocytes. The virus
binds specifically to the CD4 receptors on these cells using the glycoprotein spikes on the surface
of the virus particles.” [6]. Although the patient immune system does produce antibodies to attack
the virus, it is only successful at constraining the virus. After a medium of 8-10 years the patient
develops aids. The production of antibodies to fight HIV is when the patient is categorised as HIV
positive.
Figure 3.1: Development of HIV over short and long term time scale, alongside the change in CD4+
T cell count and the virus level. Each variable is measured as the plasma concentration level [6].
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Figure 3.1 shows how the patients immune system responds to the introduction of the virus by
producing HIV antibodies, this initially works as it decreases the virus plasma concentration level,
however, it does not destroy the virus. The introduction of the virus coincides with a drop in the
CD4+ T cell plasma concentration, after the initial reduction the rate of decrease in concentration
slows. When the patient has been infected with the virus for 8-10 years, the level of CD4+ T cell
plasma concentration reduces further as the virus awakes from a dormant period, this coincides
with a decrease in the HIV antibody concentration level.
Whilst the virus is in a semi steady state, the patient doesn’t display any symptoms of the virus.
Therefore, it is important to diagnose the patient with HIV during the first 2-10 weeks. Fail-
ure to diagnose the patient will prevent any drug therapy being used to slow down the disease,
whilst simultaneously increasing the likelihood of the patient infecting other individuals with HIV.
Education as mentioned earlier in Chapter 2 is essential to slow the spread of a virus such as HIV.
2 Drug Therapy to Treat HIV
2.1 Linear Model to Predict the Quantity of Viral Peptides Produced
David Ho prescribed a HIV protease inhibitor to 20 subjects who had the HIV-1 virus and recorded
how they responded to treatment [7]. He proposed a simple linear first order equation to model
how the introduction of protease inhibitor may reduce the amount of viral peptides. He used the
following
dV
dt
= p− cv,
where p is the source of viral peptides, and c the viral clearance rate. If we assume that the drug
is completely effective then p = 0. Therefore,
dV
dt
= −cv,
so
V (t) = V (0)e−ct. (3.1)
Ho then used data collected from his subjects to calculate a half life of t 1
2
= 2.1 ± 0.4 days. He
then substituted this into (3.1) and found that the model predicts that one billion viral particles
are produced daily, contrary to previous assumptions that, when the disease was in its semi steady
state, it was in-active. Hence, even a simple linear model can help establish how HIV develops over
time.
2.2 Combination Drug Therapy
One of the main problems with trying to treat HIV is that it mutates to drug resistant forms and
therefore it is not possible to treat patients using only one drug in the long term. The most effective
treatment is to use a combination of different drugs. This means that the virus will take longer
to evolve into a multi drug resistant form. Azidothymidine (AZT) is a transcriptase inhibitor that
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targets the protein enzymes and makes the virus non-infectious.
The mathematical model Perelson and Nelson in their paper Mathematical Analysis of HIV-1
[6], proposed a suitable combination drug therapy model. The model proposed is a four species
model that includes equations with the following unknowns
• the uninfected T-cells, T,
• the productively infected T-cells, T ∗,
• the infectious viruses, VI , and
• the noninfectious viruses, VNI .
The system of differential equations describing the model is
dT
dt
= s+ pT
(
1− T
Tmax
)
− dTT − kVIT = f(T, T ∗, VI , VNI),
dT ∗
dt
= (1− nrt)kVIT − δT ∗ = g(T, T ∗, VI , VNI),
dVI
dt
= (1− np)NδT ∗ − cVI = h(T, T ∗, VI , VNI),
dVNI
dt
= npNδT
∗ − cVNI = z(T, T ∗, VI , VNI).
(3.2)
Here np and nrt denote, respectively, the measure of effectiveness of the inhibitor prescribed to
block the production of virus particles and of the RT-inhibitor taken. RT-inhibitor is a reverse
transcriptase drug such as AZT. Where s, p, Tmax, dT and k are all positive constants, and s
represents the source of the viral particles and −dT is the clearance term. We can see from the
model that, when nrt = 1 no T-cells are produced, therefore the drug is completely effective.
Similarly, if nrt = 0, no RT-inhibitor has been administered and T-cells will be produced.
Stability of the model We are interested in how this model behaves, analysing the steady states
of the system to enables us to deduce the likely model predictions. First, we find the uninfected
steady state (Ts1,0,0,0), this occurs when
0 = s+ pT
(
1− T
Tmax
)
− dTT
= − p
Tmax
T 2 + (p− dT )T + s,
then
Ts1 =
(dT − p)±
√
(p− dT )2 + 4spTmax
2p
Tmax
=
Tmax
2p
[
(dT − p)±
√
(p− dT )2 + 4sp
Tmax
]
.
(3.3)
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We can easily see that one of the above roots is negative, which is rejected, since we are interested
only in positive steady states. Indeed,
Tmax
2p
[
(dT − p)−
√
(p− dT )2 + 4sp
Tmax
]
> 0
implies that
(dT − p)−
√
(p− dT )2 + 4sp
Tmax
> 0.
Thus,
(dT − p)2 > (p− dT )2 + 4sp
Tmax
,
which gives the following condition
4sp
Tmax
< 0. (3.4)
Since (3.4) cannot be true as the parameters s, p and Tmax are all positive, there is only one positive
uninfected steady state,
Ts1 =
Tmax
2p
[
(dT − p) +
√
(p− dT )2 + 4sp
Tmax
]
. (3.5)
We next study the stability of the above steady state. To do this, we first calculate the Jacobian
matrix A, of the system of equations (3.2),
A =

p
(
1− 2T
Tmax
)
− dT − kVI 0 −kT 0
(1− nrt)kVI −δ (1− nrt)kT 0
0 (1− np)Nδ −c 0
0 npNδ 0 −c
 .
Evaluating the Jacobian matrix at the steady state, we obtain
A(Ts1, 0, 0, 0) =

p
(
1− 2Ts1
Tmax
)
− dT 0 −kTs1 0
0 −δ (1− nrt)kTs1 0
0 (1− np)Nδ −c 0
0 npNδ 0 −c
 . (3.6)
Next, we calculate the eigenvalues of matrix (3.6),
|A− λI| = 0 ⇒ 0 =
∣∣∣∣∣∣∣∣∣
p
(
1− 2Ts1
Tmax
)
− dT − λ 0 −kTs1 0
0 −δ − λ (1− nrt)kTs1 0
0 (1− np)Nδ −c− λ 0
0 npNδ 0 −c− λ
∣∣∣∣∣∣∣∣∣
=
[
p
(
1− 2Ts1
Tmax
)
− dT − λ
] ∣∣∣∣∣∣
−δ − λ (1− nrt)kTs1 0
(1− np)Nδ −c− λ 0
npNδ 0 −c− λ
∣∣∣∣∣∣
=
[
p
(
1− 2Ts1
Tmax
)
− dT − λ
]
[−(1− nrt)kTs1[(1− np)Nδ(−c− λ)]
+ (−c− λ)2(−δ − λ)].
(3.7)
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Hence, we can see that
λ1 = p(1− 2Ts1
Tmax
)− dT .
Moreover,
0 = (1− nrt)kTs1[(1− np)Nδ(−c− λ)]− (−c− λ)2(−δ − λ)
= (−c− λ)[(1− nrt)(1− np)kTs1Nδ − (−c− λ)(−δ − λ)]
= (−c− λ)[(1− nc)kTs1Nδ − (−c− λ)(−δ − λ)],
(3.8)
where nc = (1 − nrt)(1 − np) represents the effectiveness of combination drug therapy treatment.
Thus, the second eigenvalue is
λ2 = −c.
Next, we calculate the other two eigenvalues. We have
0 = (1− nc)kTs1Nδ − (−c− λ)(−δ − λ)
= λ2 + (c+ δ)λ− (1− nc)NδkTs1 + cδ.
Which implies that
λ3,4 =
−(c+ δ)±√(c+ δ)2 + 4(1− nc)NδkTs1 − 4cδ
2
=
−(c+ δ)
2
± 1
2
√
(c+ δ)2 + 4(1− nc)NδkTs1 − 4cδ.
To establish whether the steady states are imaginary or real, we analyse the sign of the square root
term.
(c+ δ)2 + 4(1− nc)NδkTs1 − 4cδ = (c− δ2) + 4(1− nc)NδkTs1,
which is a positive quantity as (1 − nc), N , δ, k and Ts1 are all positive. We can thus conclude
that the third and fourth steady states are also real. For the steady state to be stable we require
the eigenvalues to be negative. From an initial inspection it is apparent that λ2 and λ4 are both
negative. We can also see that λ1 is negative if
Ts1 >
1
2p
(p− dT )Tmax,
which is satisfied from (3.5). Hence, we will next investigate the sign of the fourth eigenvalue. Let
us assume that it is negative, namely
−(c+ δ)
2
+
1
2
√
(c+ δ)2 + 4(1− nc)NδkTs1 − 4cδ < 0,
which implies
(c+ δ)2 + 4(1− nc)NδkTs1 − 4cδ < (c+ δ)2.
Thus,
4(1− nc)NδkTs1 − 4cδ < 0.
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Re-arranging yields,
1− c
NkTs1
< nc. (3.9)
We can thus conclude that the steady state Ts1 is stable under the assumption (3.9). The stability
condition says that if the treatment is strong enough, the virus level will fall below detectable levels.
From the system of equations (3.2), we can see that at the pre-treatment steady state
1
δ
(1− nrt)kVIT0 = T ∗.
Therefore,
0 = (1− np)NδT ∗ − cVI ,
= (1− np)Nδ1
δ
(1− nrt)kVIT0 − cVI ,
= (1− np)(1− nrt)kNT0 − c.
(3.10)
From which we can conclude that
c = (1− nc)kNT0.
At the pre-treatment steady state no drug therapy has been administered. Therefore,
nc = 0 ⇒ NkT0 = c,
i.e.,
1− T0
Ts1
< nc. (3.11)
If the patient is only administered with one drug, namely if they are prescribed the inhibitor to
block virus particles but not the RT-inhibitor, then nrt = 0. Hence, (3.11) gives that
np > 1− T0
Ts1
. (3.12)
Using values Perelson and Nelson [6] found to be typical, such that the normal level of T-cell count
in a uninfected person is around 1000/µL, and a patient is diagnosed with AIDS when the level
drops below 200/µL, we find that np > 0.8. This means that, if the drug is only administered at
such a late point in the development of the virus, the drug has to be very strong to have an effect.
Meanwhile if we assume that Ts1 = 1000 and T0 = 500, then np > 0.5. Therefore, the earlier the
drug treatment starts, the less strong the treatment has to be in order to be effective [6]. However,
if we administer both drugs at the same time, we see the following relationship
Nc = 1− (1− np)(1− nrt) < 1− T0
Ts1
.
If we now let T0 = 200 and Ts1 = 1000, then we only need np = 0.55 and nrt = 0.55. Hence, by
using combination drug therapy, less strong drug are needed to be effective in reducing the level of
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virus particles. Next, we explore whether there exists an infected steady state. At a steady state
the following is true
s+ pT
(
1− T
Tmax
)
− dTT − kVIT = 0, (3.13)
(1− nrt)kVIT − δT ∗ = 0, (3.14)
(1− np)NδT ∗ − cVI = 0, (3.15)
npNδT
∗ − cVNI = 0. (3.16)
Using equation (3.15) we can see that
T ∗ =
cVI
(1− np)Nδ .
Substituting T ∗ into equation (3.14) gives
0 = (1− nrt)kVIT − δ cVI
(1− np)Nδ
= VI
(
(1− nrt)kT − c
(1− np)N
)
= (1− nrt)kT − c
(1− np)N .
Therefore,
(1− nrt)kT = c
(1− np)N ,
from which we can conclude that
Ts2 =
c
(1− nrt)(1− np)Nk
=
c
(1− nc)Nk.
(3.17)
Now that we have the infected steady state T count we can substitute this into equation (3.14) to
find VˆI , the VI at the infected steady state. We have
s+ pTs2
(
1− Ts2
Tmax
)
− dTTs2 − kVITs2 = 0,
i.e.,
s+ pTs2
(
1− Ts2
Tmax
)
− dTTs2 = kVITs2.
Thus,
s
kTs2
+
1
k
(
p
[
1− Ts2
Tmax
]
− dT
)
= VˆI . (3.18)
Using (3.18) we can find the value for T ∗ at the infected steady state Tˆ ∗. From (3.15) we get that
Tˆ ∗ =
cVˆI
(1− np)Nδ .
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The last value we need to evaluate is VˆNI . Substituting Tˆ
∗ into (3.16) we find
VˆNI =
npNδT
∗
c
=
npVI
1− np .
As before nc = 1− (1− nrt)(1− np), therefore in absence of drugs nc = 0, and when the drugs are
less than perfect 0 < nc < 1. This infected steady state is only relevant if the virus exists, that is
VˆI > 0, so
0 <
s
kTs2
+
1
k
(
p
[
1− Ts2
Tmax
]
− dT
)
<
s
Ts2
+ p− pTs2
Tmax
− dT
< − pT
2
s2
Tmax
+ Ts2(p− dT ) + s.
(3.19)
However, if VI = 0 then
Ts2 =
−(p− dT )±
√
(p− dT )2 + 4 ps
Tmax
− 2p
Tmax
=
Tmax
2p
[
(p− dT ) +
√
(p− dT )2 + 4 ps
Tmax
]
= Ts1.
Hence, at VI = 0 the infected and uninfected steady states merge as expected due to the absence
of the virus.Moreover, according to (3.19), we can see that as Ts2 decreases, the left hand side of
(3.19) increases. Therefore, when VI > 0 it implies that 0 < Ts2 < Ts1. This is what we would
expect to happen from the biological explanation of how the virus would behave. If we substitute
our value for Ts2 from equation (3.17) into equation (3.19) we have
(1− nc)Ns
c
+
1
k
(
p
(
1− c
TmaxNk(1− nc)
)
− dT
)
> 0.
Now in the case s = 0 the virus is no longer producing any viral particles,
1
k
(
p
(
1− c
TmaxNk(1− nc)
)
− dT
)
> 0
p
(
1− c
TmaxNk(1− nc)
)
− dT > 0,
as dT > 0 we can assume that
p
(
1− c
TmaxNk(1− nc)
)
> 0,
which implies
c
Tmax(1− nc) < Nk ⇒ VI > 0.
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Therefore, the following is also true
c
Tmax(1− nc) > Nk ⇒ VI < 0.
If we analyse the stability at this steady state, where there is no new production of viral particles,
we will be able to see if the virus tends to such a position. If we let Tˆ = Ts2, and s = 0, we can
calculate the Jacobian J matrix of the system (3.2),
J =

p
(
1− 2Tˆ
Tmax
)
− dT − kVˆI 0 −kTˆ 0
(1− nrt)kVˆI −δ (1− nrt)kTˆ 0
0 (1− np)Nδ −c 0
0 npNδ 0 −c
 .
Therefore,
|J − λI| = 0 ⇒ 0 =
∣∣∣∣∣∣∣∣∣
p
(
1− 2Tˆ
Tmax
)
− dT − kVˆI − λ 0 −kTˆ 0
(1− nrt)kVˆI −δ − λ (1− nrt)kTˆ 0
0 (1− np)Nδ −c− λ 0
0 npNδ 0 −c− λ
∣∣∣∣∣∣∣∣∣
= (−c− λ)
∣∣∣∣∣∣∣
p
(
1− 2Tˆ
Tmax
)
− dT − kVˆI − λ 0 −kTˆ
(1− nrt)kVˆI −δ − λ (1− nrt)kTˆ
0 (1− np)Nδ −c− λ
∣∣∣∣∣∣∣ .
(3.20)
Hence, we can see that the first eigenvalue is λ1 = −c. Calculating the other eigenvalues, we get∣∣∣∣∣∣∣
p
(
1− 2Tˆ
Tmax
)
− dT − kVˆI − λ 0 −kTˆ
(1− nrt)kVˆI −δ − λ (1− nrt)kTˆ
0 (1− np)Nδ −c− λ
∣∣∣∣∣∣∣ = 0.
Calculating the determinant produces[
p
(
1− 2Tˆ
Tmax
)
− dT − kVˆI − λ
] [
(−δ − λ)(−c− λ)− (1− np)Nδ(1− nrt)kTˆ
]
− (1− nrt)kVˆI [kTˆ δN(1− np)] = 0,
which implies [
p
(
1− 2Tˆ
Tmax
)
− dT − kVˆI − λ
] [
(−δ − λ)(−c− λ)− (1− nc)δNkTˆ
]
− kVIkTˆ δN(1− nc) = 0.
(3.21)
By using the steady state value for Tˆ , that is
Tˆ =
c
Nk(1− nc) , (3.22)
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it is possible to simplify (3.21), so that[
p
(
1− 2Tˆ
Tmax
)
− dT − kVˆI − λ
] [
(−δ − λ)(−c− λ)− (1− nc)δNkc
Nk(1− nc)
]
− kVˆIkδNc(1− nc)
Nk(1− nc) = 0,
(3.23)
i.e.,
0 =
[
p
(
1− 2Tˆ
Tmax
)
− dT − kVˆI − λ
]
[(−δ − λ)(−c− λ)− δc]− kVˆIδc
=
[
p
(
1− 2Tˆ
Tmax
)
− dT − kVˆI − λ
] [
λ2 + (δ + c)λ
] − kVˆIδc. (3.24)
Since equation (3.24) is of the form λ3 + Aλ2 +Bλ+ C = 0, where
A = δ + c+
2pTˆ
Tmax
− (p− dT ) + kVI ,
B = (δ + c)
[
2pTˆ
Tmax
− (p− dT ) + kVI
]
, C = cδkVI .
For stability purposes we do not need to evaluate the exact values for the eigenvalues, we just need
to determine whether or not they are positive or negative. For the steady state to be stable we
require the eigenvalues to have a negative real part. Routh-Hurwitz stability criterion shows that
if A > 0,C > 0 and AB − C > 0, then the eigenvalues do have a negative real part [11]. We can
tell from an initial inspection that C > 0 as it is made up of three constants which are all greater
than zero and VI which is the number of infectious viral particles that cannot be negative. From
equation (3.13), we can deduce that
s+ pTˆ
(
1− Tˆ
Tmax
)
− dT Tˆ = kVˆI Tˆ ,
as s = 0 it implies that
pTˆ − pTˆ
2
Tmax
− dT Tˆ < kVˆI Tˆ
(p− dT ) < kVˆI + pTˆ
Tmax
.
(3.25)
Hence, we can see from equation (3.25) that A > 0. Next, we need to prove the last Routh-Hurwitz
condition, that AB − C > 0. Therefore,
A = δ + c+
2pTˆ
Tmax
− (p− dT ) + kVˆI ,
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by letting
B1 =
2pTˆ
Tmax
− (p− dT ) + kVˆI ,
we get that
A = δ + c+B1, B = (δ + c)B1.
From which we can conclude that
AB = (δ + c)2B1 + (δ + c)B
2
1
= (δ + c)2
[
2pTˆ
Tmax
− (p− dT ) + kVˆI
]
+ (δ + c)
[
2pTˆ
Tmax
− (p− dT ) + kVˆI
]2
= (δ2 + 2δc+ c2)
[
2pTˆ
Tmax
− (p− dT ) + kVˆI
]
+ (δ + c)B21 > 2δckVˆI > δckVˆI = C,
which implies
AB > C ⇒ AB − C > 0.
Therefore, if the steady state exists then it is classified as a stable steady point. As we showed
earlier Ts2 < Ts1, if Ts2 exists. We also deduced from (3.9) that
1− c
NkTs1
< nc. (3.26)
Therefore, if the stability condition (3.26) is not satisfied, then the only non-negative steady state
is Ts1, hence there is no infected steady state. However, if (3.26) holds true, then there exists an
infected stable steady state at Ts2 . Therefore, we can deduce that there is a transcritical bifurcation
point when c = NkTs1(1− nc).
Chapter 4
Numerical Approximations of Epidemic
Models
Throughout the previous chapters, we have used computer algorithms to accurately predict solu-
tions for the different population models, with specified initial conditions. For models where we
cannot obtain explicit analytic formulas which show the trajectories as elementary functions, we
can implement numerical methods that compute an approximate solution [3]. For example, when
Kermack and McKerndrick solved the SIR model to find an explicit solution [9], they used the
Taylor expansion when expanding the e−
R
p term. When applying the exact solution shown in (1.25)
to our Bombay epidemic problem, the size of recovered population reaches 20, 000. The Taylor
expansion is not accurate for such high values of R as shown in Figure 4.1.
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Figure 4.1: Comparison between e−
R
p and the third term Taylor expansion.
Therefore, the exact solution will not be accurate when the size of the recovered population gets
to large. If we graph the exact solution against an inbuilt Matlab solver approximation we see this
relation. Figure 4.2, shows how the exact solution is fine until the Recovered population exceeds
around 6000. This is at as similar value to when the Taylor expansion is no longer accurate. As
the recovered population is also a parameter in the explicit solution for the infected and susceptible
populations, the Taylor expansion error effects all three solutions.
37
CHAPTER 4. NUMERICAL APPROXIMATIONS OF EPIDEMIC MODELS 38
0 5 10 15 20 25 30
Weeks
-2000
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
S(t), I(t), R(t)
S
I
R
Figure 4.2: Comparison between explicit solution and the Ode45 approximation of the SIR model.
The explicit solution is shown as the dotted lines.
Due to the error caused by the Taylor expansion in the derivation of the explicit solution, there
are a variety of numerical approximations we can use to obtain a more accurate solution to the
SIR model. In this chapter we will discuss a number of these, whilst investigating shortcomings
associated with each method.
1 Explicit Euler Approximation
One of the simplest numerical approximations to calculate is the explicit Euler method. Let’s begin
with the following initial value problem,
y′(t) = f(t, y), y(t0) = y0, (4.1)
where f(t, y) is a known function, and we want to solve (4.1) in the time interval [t0, tf ]. Since the
initial value is known, it is possible to approximate y(t0+h) where h is the step size we want to use,
using y0 + hf(t0, y0) [3]. Therefore if we let y1 = y0 + hf(t0, y0), then we can use the same method
to calculate y2, as y2 = y1 + hf(t1, y1) where t2 = t1 + h. Thus we can continue using this iteration
until we get to the final point in our time interval tf . This approximation technique is the explicit
Euler method. We can therefore display the following explicit Euler formula for approximating
yn+1,
yn+1 = yn + hf(tn, yn), (4.2)
where h is the step size of the the approximation. Figure 4.3 illustrates how the explicit Euler
method approximates the solution, we can deduce that if the gradient is close to one then the
approximation will be more accurate than when the gradient is much larger, where a smaller step
size will be required to produce an accurate approximation. Since the explicit Euler method is a
first order approximation, if we reduce the step size by a half we will in turn reduce the error by a
half.
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Figure 4.3: Schematic illustration of the explicit Euler method [1].
We can use the explicit Euler method to approximate the solution to SIR model for the Bombay
plague epidemic discussed in chapter 1. Using the initial values and parameters Kermack and
McKendrick [9] suggested, we can approximate the solution.
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Figure 4.4: Euler approximations denoted by the crosses and Ode45 approximations denoted by
the solid lines, of the Bombay plague epidemic SIR model using different number of steps.
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Figure 4.4 shows that as we increase the number of steps of Euler uses, the approximation tends
to the Ode45 solution.
2 Classical Fourth Order Runge Kutta Approximation
Although the explicit Euler method may produce a good approximation, we may require a more
accurate approximation. A fourth order approximation will converge to the exact solution much
quicker than a first order approximation. Higher order methods will produce more accurate ap-
proximations, however such methods require longer calculations. Therefore when deciding which
calculation to use, we must balance the accuracy of the approximation, against the length of time
required for the computation. The classical fourth order Runge Kutta approximation measures the
slope at the mid-point and end points of the interval, a weighted average is then taken where more
weight is placed on the slope at the mid point. Thus to approximate the solution of the initial value
problem,
y′(t) = f(t, y), y(t0) = y0 (4.3)
the following classical fourth order Runge Kutta method can be used,
K1 = hf(t, yn),
K2 = hf(t+ 0.5h, yn + 0.5K1),
K3 = hf(t+ 0.5h, yn + 0.5K2),
K4 = hf(t+ h, yn +K3),
yn+1 = yn +
1
6
(K1 + 2K2 + 2K3 +K4).
(4.4)
Inputting the same parameter values as we did earlier, when approximating the solution to the
SIR model for the Bombay plague epidemic, we can use the classical fourth order Runge Kutta
approximation to produce Figure 4.5.
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Figure 4.5: Approximation of the SIR Bombay epidemic model using the classical fourth order
Runge Kutta method.
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To deduce which approximation is more accurate we compare the errors of the corresponding ap-
proximations. As we do not have the exact solution of the SIR model, we will use the inbuilt
Ode45 Matlab solver at at a really low tolerance setting as our exact solution. Figure 4.6 shows
that the error of the explicit Euler approximation is much greater than that of the Runge Kutta
approximation.
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Figure 4.6: The error of the numerical approximations of the Bombay plague epidemic SIR model
using a step size of h = 0.001 for the explicit Euler method and h = 0.1 for the Runge Kutta
method.
However, as we discussed earlier we have to balance this increased accuracy against how long it takes
to compute the approximation. Table 4.1 shows that the Runge Kutta method takes considerably
longer to compute in comparison with the explicit Euler method. To produce an approximation
with a step size of 0.001, the Runge Kutta method takes 5.7 times longer than the explicit Euler
method. Therefore, although we getter a more accurate approximation using a higher order method,
it takes considerably longer to produce. Thus, when deciding which method to use, we must deduce
the preferred combination of accuracy and computational time.
Time taken to compute
the approximations (seconds)
Step Size Euler Fourth order Runge Kutta
0.1 0.177 0.194
0.01 0.203 0.265
0.001 0.402 2.304
0.0001 2.504 19.625
Table 4.1: Time taken to compute the approximate solution to the SIR model at varying step sizes.
We can use the same Runge Kutta formula to approximate the solution to the HIV population model
discussed in chapter two. Figure 4.7 shows the relation between the different population classes, it
demonstrates how similar the classical Runge Kutta method is to the Matlab ode45 inbuilt solver.
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Figure 4.7: Approximation of the HIV population epidemic model using the classical fourth order
Runge Kutta method, represented by the dotted lines, and by using the ode45 inbuilt Matlab solver.
If we compare the Runge Kutta approximation with the Euler approximation of HIV model we can
see that the Euler approximation is less accurate when there is a greater change in the solution.
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Figure 4.8: Approximation of the HIV population epidemic model using the classical fourth order
Runge Kutta method and the explicit Euler method shown by the dotted lines.
3 Experimental Order of Accuracy
The Experimental Order of Accuracy (EOC) of an approximation shows how quickly the error
decreases in response to a decrease in step size. If the exact solution is known then we can calculate
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the error of the approximation, and thus the EOC is as follows,
EOC =
log
∣∣∣ n+1n ∣∣∣
log
∣∣∣hn+1hn ∣∣∣ (4.5)
where n is the error of the approximation at the n
th step. If we decrease the step size by a half,
a first order approximation should have an EOC of one, a second order approximation an EOC of
two and so on. If we do not know the exact solution then Olof Runborg in his paper “Numerical
Solutions of Differential Equations” [16], suggests two alternative methods. The first is to calculate
the approximation at a very small step size and then treat this as the exact solution, this will enable
us to use equation (4.5) to find the EOC. The second method is to compare the solution at varying
step sizes. If we let yˆh be the approximate solution with a step size of h, then we can formulate the
EOC as follows,
EOC = log2
∣∣∣∣∣ yˆh − yˆh2yˆh
2
− yˆh
4
∣∣∣∣∣ . (4.6)
Using this formula we can now calculate the EOC of the explicit Euler and classical fourth order
Runge Kutta approximations. We would expect the order of convergence to be approximately four
for the Runge Kutta method and one for the forward Euler method. Applying the fourth order
Runge Kutta approximation to the Bombay plague SIR model we see that as we decrease the step
size, the EOC gets closer to four.
step size (h) R(30) Rˆh − Rˆh
2
Rˆh−Rˆh
2
Rˆh
2
−Rˆh
4
log2
(
Rˆh−Rˆh
2
Rˆh
2
−Rˆh
4
)
0.3 1.251775186308588 ×104 -2.74×10−3 1.54E+01 3.940657
0.15 1.251775460670866 ×104 -1.79×10−4 1.57E+01 3.970058
0.075 1.251775478538557 ×104 -1.14×10−5 1.58E+01 3.984883
0.0375 1.251775479678707 ×104 -7.20×10−7 1.60E+01 3.996997
0.01875 1.251775479750717 ×104 -4.51×10−8 1.61E+01 4.008989
0.009375 1.251775479755228 ×104 -2.80×10−9
0.004688 1.251775479755508 ×104
Table 4.2: This table uses the method shown in (4.6) to calculate the EOC values for the Runge
Kutta method, using the approximated values of the Recovered population after 30 weeks.
Table 4.2 shows the EOC values at a specific point in time. Using Matlab we can calculate the
EOC at every time point in the approximation. Figure 4.9 shows the results of these calculations,
it is apparent that the EOC converges to four as we reduce the step size at every time point.
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Figure 4.9: EOC of the Runge Kutta approximation of the SIR Bombay epidemic model at varying
step sizes (h).
4 Adaptivity
Adapting the step size so that it is very small when we have a large change in the gradient of
the solution, whilst using a larger step when there is less change, will enable us to produce a
more efficient approximation. We will now investigate how adaptive step size controls work in the
Ode45 solver and how it affects the solution. In 1969 Erwin Fehlberg introduced a Runge Kutta
approximation that applied six function evaluations per step, this method was used by F.Shampine
and his colleague H.A.Buddy to create the ODE solver RKF45. The formula for this method is
illustrated below,
K1 = hf(ti, yi)
K2 = hf
(
ti +
h
4
, yi +
1
4
K1
)
K3 = hf
(
ti +
3
8
h, yi +
3
32
K1 +
9
32
K2
)
K4 = hf
(
ti +
12
13
h, yi +
1932
2197
K1 − 7200
2197
K2 +
7296
2197
K3
)
K5 = hf
(
ti + h, yi +
439
216
K1 − 8K2 + 3680
513
K3 − 845
4104
K4
)
K6 = hf
(
ti +
h
2
, yi − 8
27
K1 + 2K2 − 3544
2565
K3 +
1859
4104
K4 − 11
40
K5
)
where the fifth order approximation is given by,
zi+1 = zi +
25
216
K1 +
1408
2565
K3 +
2197
4104
K4 − 1
5
K5
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and the fourth order approximation as,
yi+1 = yi +
16
135
K1 +
6656
12825
K3 +
28561
56430
K4 − 9
50
K5 +
2
55
K6
This algorithm was the base for the creation of the ODE45 Matlab solver, this method was used for
fifteen years until it was updated to a more efficient algorithm. The method which replaced it was
the Dormand and Prince approximation, which uses a pair of Runge Kutta formulas derived for local
extrapolation. The method developed by Dormand and Prince also uses six function evaluations to
produce a fourth and fifth order Runge Kutta approximation solutions, as shown below,
K1 = hf(ti, yi)
K2 = hf
(
ti +
h
5
, yi +
1
5
K1
)
K3 = hf
(
ti +
3
10
h, yi +
3
40
K1 +
9
40
K2
)
K4 = hf
(
ti +
4
5
h, yi +
44
45
K1 − 56
15
K2 +
32
9
K3
)
K5 = hf
(
ti +
8
9
h, yi +
19372
6561
K1 − 25360
2187
K2 +
64448
6561
K3 − 212
729
K4
)
K6 = hf
(
ti + h, yi +
9017
3168
K1 − 355
33
K2 +
46732
5247
K3 +
49
176
K4 − 5103
18656
K5
)
K7 = hf
(
ti + h, yi +
35
384
K1 +
500
1113
K3 +
125
192
K4 − 2187
6784
K5 +
11
84
K6
)
where the fifth order approximation is given by,
zi+1 = zi +
35
384
K1 +
500
1113
K3 +
125
192
K4 − 2187
6784
K5 +
11
84
K6
and the fourth order approximation as,
yi+1 = yi +
5179
57600
K1 +
7571
16695
K3 +
393
640
K4 − 92097
339200
K5 +
187
2100
K6 +
1
40
K7
The Matlab Ode45 solver uses an adaptive step size, it calculates the difference between the fourth
and fifth order approximation which is said to be the error of the fourth order approximation. This
error is then used to determine the step size used for the approximation at the next point. Although
the Dormand and Prince method has seven stages, it only uses only six function evaluations as the
first stage is the same as the last stage for the previous step. They choose the coefficients to
minimize the fifth order approximation error, this is the main difference to the Fehlberg method
which opted to minimize the fourth order approximation error. The Dormand and Prince method is
a local extrapolation method as the higher order solution is used to continue the approximation at
the next step. Calculating the experimental order of convergence of the fourth order approximation
at different step sizes confirms that this Dormand and Prince method is of order four.
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Step Size Dormand and Prince EOC
Fourth Order Approximation
1 1.67523957168987×10−4 4.069
0.5 1.67523569650797×10−4 4.089
0.25 1.67523546566328×10−4 4.064
0.125 1.67523545209468×10−4 4.038
0.0625 1.67523545128365×10−4 4.021
Table 4.3: Dormand and Prince fourth order approximation of the recovered population at t=30
weeks, along with the corresponding order of convergence values.
If we then calculate the EOC of the fifth order Dormand and Prince method we see that this also
confirms it as a fifth order approximation.
Step Size Dormand and Prince EOC
Fifth Order Approximation
1 1.675236787616821×10−4 4.6396
0.5 1.675235504595664×10−4 4.813
0.25 1.675235453125618×10−4 4.856
0.125 1.675235451294154×10−4 5.007
Table 4.4: Dormand and Prince fifth order approximation of the recovered population at t=30
weeks, along with the corresponding order of convergence values.
By calculating the Truncation error coefficients we can compare the efficiency of the different ap-
proximations, where “The local truncation error at any time point in the integration interval is
the numerical error due to the truncation of terms, if one assumes that the previous solution used
to calculate the solution at the next time point is exact” [10]. F.Shampine proposed in the paper
“Some Practical Runge-Kutta Formulas” [17], that we by implementing the following formula we
could establish the local truncation error coefficients,
||Tp+1||2 =
(
λp+1∑
j=1
T 2p+1
) 1
2
where p is the order of the approximation. If we want to compare the relative efficiency of two
methods say A and B, then Shampine proposed calculating the following computable relation will
enable us to compare efficiency,
CB
CA
(
||TBp+1||
||TAp+1
) 1
p
(4.7)
where CA is the amount of evaluations method A takes. By implementing these two formulas she
deduced that the Dormand and Prince method was 11% more efficient than the Fehlberg method.
Thus the improved Ode45 solver is more efficient due to replacing the Fehlberg formula with the
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Dormand and Prince version.
When using the Ode45 solver in Matlab it is important to have the correct Tolerance settings,
otherwise the level of accuracy of the approximation will be reduced. The relative tolerance is a
measure of the error relative to the size of solution at any point in the approximation, it has a
default setting of 1× 10−3 for Ode45 in Matlab. Meanwhile the absolute tolerance is the threshold
at point i in the approximation where the value of the solution is no longer important. Thus the
absolute tolerance setting is very important for solutions close to zero and has a default setting of
1×10−6 for Ode45 in Matlab. The Ode45 solver calculates the local error as the difference between
the fourth and fifth order approximations, this must be less than or equal to specified acceptable
error which is a function of absolute tolerance and relative tolerance as shown below,
tolerancej = max(|ykj | × RelTol,AbsTolj).
We can see from the equation above that the relative tolerance is a scalar but the absolute tolerance
is a vector, this enables us to set an absolute tolerance for each individual parameter. Therefore we
can see that Ode45 adapts the step size depending on the relation between the pre-selected tolerance
settings and the local error estimation. We can see from table 4.5, that when we reduce the absolute
tolerance level the number of steps that ode45 takes increases, this arises from a smaller acceptable
error size.
Absolute Tolerance Setting Number of successful Steps ode45 Took
1× 10−3 85
1× 10−6 115
1× 10−10 151
Table 4.5: Comparison between the absolute tolerance setting and the number of steps the ode45
Matlab solver used when approximating the solution of the SIR epidemic model, whilst the relative
tolerance was set to default.
We obtain a similar relation when we reduce the relative tolerance setting, however in comparison
to the same reduction in absolute tolerance, the number of steps increases much quicker due to an
decrease in relative tolerance. This is to be expected as all three of the parameters S,I and R do
not spend a lot of time close to zero in the approximation.
Relative Tolerance Setting Number of successful Steps ode45 Took
1× 10−3 115
1× 10−6 361
1× 10−10 1105
Table 4.6: Comparison between the relative tolerance setting and the number of steps the ode45
Matlab solver used when approximating the solution of the SIR epidemic model, whilst the absolute
tolerance was set to default.
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Comparing how ode45 compares against a different Nonstiff Matlab solver such as ode23, we see that
to achieve the same relative tolerance error level, ode23 has to take many more steps than ode45.
The ode23 Matlab solver uses a combination of second and third order Runge Kutta formulas in a
similar fashion to how ode45 works [4].
Relative Tolerance Setting ode45 ode23
1× 10−3 115 151
1× 10−4 181 307
1× 10−5 241 646
1× 10−6 361 1342
1× 10−7 529 2686
1× 10−8 763 5023
Table 4.7: Comparison between of the number of successful steps the ode45 and ode23 Matlab
solvers used at different relative tolerance setting when approximating the solution of the SIR
epidemic model, whilst the absolute tolerance was set to default.
If we now compare the ode45 solver which implements adaptivity, against the Dormand and Prince
approximation with a step size of 0.25, we can see that there is not a lot of difference in the
solutions, however the use of adaptivity by ode45 reduces the number of steps necessary to produce
an accurate solution by only decreasing the step size when there is an unacceptable local error.
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Figure 4.10: The solution to the SIR model using the Matlab inbuilt command function ode45,
and using the Dormand and Prince fifth order Runge Kutta method with a step size of 0.25. The
Dormand and Prince approximation is shown using the dotted lines. The graph on the right is
a zoomed in version of the one on the left where the susceptible and recovered population lines
intersect.
If we now look at the phase plane diagram of the SIR model during the Bombay plague epidemic
we can see that through looking at different initial population levels, we can reproduce the phase
plane diagram we expected to get using the theory shown in Figure 1.3.
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Figure 4.11: The phase plane diagram for SIR Bombay epidemic model using different initial
conditions.
Therefore regardless of the initial conditions the Infected population will always tend to zero over
time. We can also confirm a relation we discovered analyticity earlier, that the peak in the Infected
population occurs when S = p, if S0 > p. In this chapter we have shown how numerical approx-
imations can provide accurate solutions to problems when we cannot obtain the explicit analytic
solutions. Furthermore, we have been able to confirm expected behaviors and relations between
different parameters. Thus, we have shown how important numerical approximations are when
investigating population models.
Chapter 5
Conclusion
We began this investigation into mathematical modelling by explaining the process for selecting a
suitable epidemiological model. To achieve this we had to identify the key parameters that effect
the populations we intended to model. Once a model is selected we can compare the modelled
predictions against the real data collected. In the case of our SIR model, Kermack and McKendrick
compared the model against data collected from the 1906 Bombay epidemic [9]. They found that
by carefully selecting the parameters, they could accurately model the change in the recovered pop-
ulation.
We then investigated the problem posed by diseases which are harder to model. An example of such
a problem is modelling how HIV is spread through a population. Murray suggests the use of a epi-
demic model consisting of four population classes [12]. The proposed demographic model included
realistic assumptions, such as there existed natural death in all four categories. We evaluated that
such a model has two steady states, one uninfected steady state and one infected, both of which are
stable. Hence it is possible that HIV will not naturally die off. Therefore it becomes important that
there are effective treatments which can reduce the spread of HIV and prevent an epidemic occurring.
Thus, we investigated the biological make up of HIV and deduced that drug therapy was the most
effective treatment. Perelson and Nelson created a suitable combination drug therapy model [6].
This modelled how certain drugs effect not only the level of virus particles, but also the production
of T-cells, which are vital in the function of the immune system. We concluded that there existed
an uninfected and infected steady state. Again we evaluated that both states were stable, where
there existed a transcritical bifurcation point at c = NkTs1(1 − nc). Therefore the viral clearance
rate is highly dependent on the effectiveness of the drug therapy nc. Earlier in this chapter we
showed that administering more than one drug increases the effectiveness of the therapy and thus
slows down the transmission of the virus. We can therefore conclude that to tackle HIV effectively,
we require a combination of quick diagnosis and effective drug therapy.
For models such as the ones used in this paper we cannot find accurate analytical solutions. Thus
numerical approximations become extremely important in the analysis of such models. Therefore
we have investigated several numerical methods to deduce the advantages and disadvantages of
such methods. We concluded that although higher order methods are more accurate, the increase in
computational time has to be balanced against the need for such a high degree of accuracy. Therefore
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we analysed adaptive numerical approximations to evaluate how they can improve efficiency. We
focused on the ode45 Matlab solver which uses two Runge Kutta methods developed by Dormand
and Prince. They used a fifth order approximation and compared the solution to one produced
by a fourth order approximation, the difference between them is classed as the relative error. The
step size is then adapted depending on the size of the relative error. Using this method we can
produce accurate approximations using less steps than a fixed step size method. To conclude, we
have shown how important mathematics can be in epidemiological modelling, we have been able to
show that through a combination of model analysis and numerical approximations of the solutions,
we can further the understanding of how epidemics occur, whilst finding ways to try and prevent
them happening.
1 Future Work
One of the major issues with approximating the SIR model is we do not have an accurate explicit
solution. This was due to the third term Taylor expansion of e−
R
p not being accurate for large
values of R. By using more terms in the Taylor expansion, it becomes more accurate. Figure 5.1,
shows how the increase in terms oscillates whilst it converges to the actual solution.
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Figure 5.1: Comparison of the numbers of terms used in the Taylor expansion of e−
R
p .
By using more Taylor expansion terms we can calculate a more accurate explicit solution for R(t).
This will enable to improve our comparison of the different numerical approximations.
During this dissertation we used a Aids model proposed by Murray [6]. This model had certain
limitations, such as it used one system of equations to model the entire homosexual population.
This meant that parameters such as the incubation period are assumed to be the same for all males
regardless of age. In reality we know that such assumptions are not realistic. Therefore we can
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use a more complex model which accounts for such differences in parameters values. Griffihs states
that “Recent research has shown that the incubation period of HIV, the virus that leads to AIDS,
is clearly age dependent” [5]. He therefore proposes the use of an age dependent model, which also
takes into account the effects of government sponsored AIDS prevention programmes. He created
a systems of equations for each of the three different age groups. This enables us to identify which
age groups should be targeted by campaigns to be most effective. We can also adapt such a model
to understand how different age groups respond to treatment programmes. Applying the analysis
in our chapter on drug therapy for HIV patients, to specific population groups may enable us to
identify more effective age dependent treatments. The successful prevention of future epidemics
depends on our ability to create effective models in order to identify those most at risk. This
will enable governments to have targeted campaigns which will have higher efficiency in combating
epidemics.
Appendices
Figure 1.1
function SIR =SIR(t,y)
r = 0.6;
a = 0.1;
SIR(1) =-r*y(1)*y(2);
SIR(2) = r*y(1)*y(2)-a*y(2);
SIR(3) = a*y(2);
SIR = [SIR(1) SIR(2) SIR(3)]’;
ylabel(’susceptible, infected, recovered’)
\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%
clear
to = 0;
tf =30;
yo = [99 01 0];
[t y] = ode45(’SIR’,[to tf],yo);
plot(t,y(:,1),t,y(:,2),t,y(:,3))
legend(’S’,’I’,’R’)
title(’SIR model’)
xlabel(’time’)
Figure 1.3
clear
t=0:1:30;
g=890*((sech(0.2*t-3.4)).^2);
plot(t,g)
xlabel(’Weeks’)
ylabel(’Deaths( \approx dR/dt)’)
53
54
Figure 4.1
r=0:20000;
p=10002.59
y=exp(-(r)/p)
plot(r,y)
hold on
y1=1-((1/p).*r)+((1/(2*p.^2))*r.^2)
plot(r,y1)
xlabel(’R’)
Figure 4.2
function rk4_bombay(a, b, N, alpha)
format long
alpha=[17986.87154 6 0]
b=30
a=0
m = size(alpha,1);
N1=50
h1 = (b-a)/N1; %the step size
t1(1) = a;
w1(:,1) = alpha; %initial conditions
t2(1) = a;
y(:,1) = alpha; %initial conditions
options=odeset(’RelTol’,1e-6,’AbsTol’,1e-6,’NonNegative’,[1 2 3]);
[t2 y1] = ode45(’bombay’,[a b],alpha, options);
r=0.00004998701123
a1=0.5 %this is a
p=10002.59843
g=0.8 %this is alpha
S=17986.87154 %this is S_0
i0=6 %this is I_0
t11=0:1:30;
R1=((a1.^2)./(r.^2 .*S)).*((r.*S./a1)-1+g.*tanh(((0.2).*t11)-3.4));
S1=S.*(exp(-((R1)/p)));
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I1=-S1+p.*log(S1)+i0+S-p.*log(S);
hold on
plot(t2,y1)
legend(’S’,’I’,’R’)
xlabel(’Weeks’)
ylabel(’S(t), I(t), R(t)’)
plot(t11,R1,’:’,t11,S1,’:’,t11,I1,’:’)
function bombay =f(t,y)
r=0.00004998701123;
a1=0.5;
bombay(1) =-r.*y(1).*y(2);
bombay(2) = r.*y(1).*y(2)-a1.*y(2);
bombay(3) = a1.*y(2);
bombay = [bombay(1) bombay(2) bombay(3)]’;
Figure 4.4
function ie(a, b, N, alpha)
hax=axes;
alpha=[22058 1 0]
b=30
a=0
N=300
m = size(alpha,1);
h = (b-a)/N; %the step size
t(1) = a;
w(:,1) = alpha; %initial conditions
for i = 1:N
t(i+1)=t(i)+h;
w(:,i+1)=w(:,i)+h*f(t(i),w(:,i));
end
hold on
plot(t,w ,’LineWidth’,2)
legend(’S’,’I’,’R’)
xlabel(’Weeks’)
ylabel(’S(t), I(t), R(t)’)
title(’Euler Approximation’)
axis([0,30,0,25000])
error=abs(1.675135451231053e4-w(3,N+1))
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function bombay =f(t,y)
r =0.000045139 ;
a = 0.5;
bombay(1) =-r*y(1)*y(2);
bombay(2) = r*y(1)*y(2)-a*y(2);
bombay(3) = a*y(2);
bombay = [bombay(1) bombay(2) bombay(3)]’;
\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%
function test1()
euler_systems(0, 30, 300, [22058 1 0]);
end
Figure 4.5
function rk4_system(a, b, N, alpha)
format long
m = size(alpha,1);
tspan=[0:1:N];
y(:,1) = alpha;
h = (b-a)/N; %the step size
t(1) = a;
w(:,1) = alpha; %initial conditions
options=odeset(’RelTol’,1e-3,’AbsTol’,1e-4,’NonNegative’,[1 2 3]);
[t1 y1] = ode45(’bombay’,tspan,alpha, options);
for i = 1:N
k1 = h*f(t(i), w(:,i));
k2 = h*f(t(i)+h/2, w(:,i)+0.5*k1);
k3 = h*f(t(i)+h/2, w(:,i)+0.5*k2);
k4 = h*f(t(i)+h, w(:,i)+k3);
w(:,i+1) = w(:,i) + (k1 + 2*k2 + 2*k3 + k4)/6;
t(i+1) = t(i) + h;
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end
length(y);
error=abs(y1-w’);
plot(t,w,’:’)
legend(’S’,’I’,’R’)
title(’Fourth order Runge Kutta’)
xlabel(’Weeks’)
ylabel(’Error’)
function bombay =f(t,y)
r =0.000045139 ;
a = 0.5;
bombay(1) =-r*y(1)*y(2);
bombay(2) = r*y(1)*y(2)-a*y(2);
bombay(3) = a*y(2);
bombay = [bombay(1) bombay(2) bombay(3)]’;
\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%
function test()
rk4_system(0, 30, 300, [22058 1 0]);
end
Figure 4.6
function rk4_systems(a, b, N, alpha)
format long
alpha=[22058 1 0]
b=30
a=0
N=3000;
m = size(alpha,1);
h = (b-a)/N;
tspan=[0:h:30];
y(:,1) = alpha;
%the step size
t(1) = a;
y(:,1) = alpha; %initial conditions
options=odeset(’RelTol’,1e-3,’AbsTol’,1e-4,’NonNegative’,[1 2 3]);
[t1 y1] = ode45(’bombay’,tspan,alpha, options);
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for i = 1:N
t(i+1)=t(i)+h;
y(:,i+1)=y(:,i)+h*f(t(i),y(:,i));
end
length(y)
error=abs(y1-y’);
plot(t,error)
legend(’S’,’I’,’R’)
xlabel(’Weeks’)
title(’Forward Euler’)
ylabel(’Error’)
function bombay =f(t,y)
r =0.000045139 ;
a = 0.5;
bombay(1) =-r*y(1)*y(2);
bombay(2) = r*y(1)*y(2)-a*y(2);
bombay(3) = a*y(2);
bombay = [bombay(1) bombay(2) bombay(3)]’;
\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%
function rk4_system(a, b, N, alpha)
format long
m = size(alpha,1);
tspan=[0:1:N];
y(:,1) = alpha;
h = (b-a)/N; %the step size
t(1) = a;
w(:,1) = alpha; %initial conditions
options=odeset(’RelTol’,1e-3,’AbsTol’,1e-4,’NonNegative’,[1 2 3]);
[t1 y1] = ode45(’bombay’,tspan,alpha, options);
for i = 1:N
k1 = h*f(t(i), w(:,i));
k2 = h*f(t(i)+h/2, w(:,i)+0.5*k1);
k3 = h*f(t(i)+h/2, w(:,i)+0.5*k2);
k4 = h*f(t(i)+h, w(:,i)+k3);
w(:,i+1) = w(:,i) + (k1 + 2*k2 + 2*k3 + k4)/6;
t(i+1) = t(i) + h;
end
length(y);
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error=abs(y1-w’);
plot(t,error)
legend(’S’,’I’,’R’)
title(’Fourth order Runge Kutta’)
xlabel(’Weeks’)
ylabel(’Error’)
function bombay =f(t,y)
r =0.000045139 ;
a = 0.5;
bombay(1) =-r*y(1)*y(2);
bombay(2) = r*y(1)*y(2)-a*y(2);
bombay(3) = a*y(2);
bombay = [bombay(1) bombay(2) bombay(3)]’;
\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%
function test()
rk4_system(0, 30, 300, [22058 1 0]);
end
function test1()
euler_systems(0, 30, 300, [22058 1 0]);
end
Figure 4.7
function rk4_aids(a, b, N, alpha)
format long
alpha = [90000 10000 0 0];
b=30
a=0
m = size(alpha,1);
N1=100
h1 = (b-a)/N1; %the step size
t1(1) = a;
w1(:,1) = alpha; %initial conditions
t2(1) = a;
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y(:,1) = alpha; %initial conditions
options=odeset(’RelTol’,1e-6,’AbsTol’,1e-6,’NonNegative’,[1 2 3]);
[t2 y1] = ode45(’aids’,[a b],alpha, options);
for i = 1:N1
k11 = h1*f(t1(i), w1(:,i));
k21 = h1*f(t1(i)+h1/2, w1(:,i)+0.5*k11);
k31 = h1*f(t1(i)+h1/2, w1(:,i)+0.5*k21);
k41 = h1*f(t1(i)+h1, w1(:,i)+k31);
w1(:,i+1) = w1(:,i) + (k11 + 2*k21 + 2*k31 + k41)/6;
t1(i+1) = t1(i) + h1;
end
hold on
plot(t1,w1)
legend(’X’,’Y’,’A’,’Z’)
function yaids =f(t,y)
B=13333.3
v=0.2
u=1/32
d=1
p=0.3
R=5.15
r=0.83
a=1
t=0:1:30;
b=0.515
c=2
N=100000
yaids(1) =B-u*y(1)-b*c*y(2)*y(1)/N;
yaids(2) = b*c*y(2)*y(1)/N-(v+u)*y(2);
yaids(3) = p*v*y(2)-(d+u)*y(3);
yaids(4)=(1-p)*v*y(2)-u*y(4);
yaids = [yaids(1) yaids(2) yaids(3) yaids(4)]’;
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Figure 4.8
function eu(a, b, N, alpha)
hax=axes;
alpha=[90000 10000 0 0];
m = size(alpha,1);
a=0
b=30
N=100
h = (b-a)/N; %the step size
t(1) = a;
w(:,1) = alpha; %initial conditions
t2(1) = a;
y(:,1) = alpha; %initial conditions
options=odeset(’RelTol’,1e-3,’NonNegative’,[1 2 3]);
[t2 y1] = ode45(’aids’,[a b],alpha, options);
for i = 1:N
t(i+1)=t(i)+h;
w(:,i+1)=w(:,i)+h*f(t(i),w(:,i));
end
hold on
plot(t,w,’:’ )
legend(’X’,’Y’,’A’,’Z’)
xlabel(’Weeks’)
ylabel(’S(t), I(t), R(t)’)
title(’Euler Approximation (N=1000)’)
function yaids =f(t,y)
B=13333.3
v=0.2
u=1/32
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d=1
p=0.3
R=5.15
r=0.83
a=1
t=0:1:30;
b=0.515
c=2
N=100000
yaids(1) =B-u*y(1)-b*c*y(2)*y(1)/N;
yaids(2) = b*c*y(2)*y(1)/N-(v+u)*y(2);
yaids(3) = p*v*y(2)-(d+u)*y(3);
yaids(4)=(1-p)*v*y(2)-u*y(4);
yaids = [yaids(1) yaids(2) yaids(3) yaids(4)]’;
Figure 4.9
function rk4_bombay(a, b, N, alpha)
format long
alpha=[17986.87154 6 0]
b=30
a=0
m = size(alpha,1);
N1=6400
h1 = (b-a)/N1; %the step size
t1(1) = a;
w(:,1) = alpha; %initial conditions
t2(1) = a;
y(:,1) = alpha; %initial conditions
options=odeset(’RelTol’,1e-3,’AbsTol’,1e-4,’NonNegative’,[1 2 3]);
[t2 y1] = ode45(’bombay’,[a b],alpha, options);
fp1=fopen(’rk4_output’, ’w’)
fprintf(fp1,’%4.2f %12.10f %12.10f %12.10f\n’, t1(1), w(1,1), w(2,1), w(3,1));
for i = 1:N1
k11 = h1*f(t1(i), w(:,i));
k21 = h1*f(t1(i)+h1/2, w(:,i)+0.5*k11);
k31 = h1*f(t1(i)+h1/2, w(:,i)+0.5*k21);
k41 = h1*f(t1(i)+h1, w(:,i)+k31);
w(:,i+1) = w(:,i) + (k11 + 2*k21 + 2*k31 + k41)/6;
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t1(i+1) = t1(i) + h1;
fprintf(fp1,’%4.2f %12.12f %12.12f %12.12f\n’, t1(i+1), w(1,i+1), w(2,i+1), w(3,i+1));
end
fclose(fp1);
hold on
w(3,N1+1)
plot(t2,y1,’r’)
function bombay =f(t,y)
r=0.00004998701123;
a1=0.5;
bombay(1) =-r.*y(1).*y(2);
bombay(2) = r.*y(1).*y(2)-a1.*y(2);
bombay(3) = a1.*y(2);
bombay = [bombay(1) bombay(2) bombay(3)]’;
\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%
function eoc_rk4()
f1=load(’rk4_output_100’);
f2=load(’rk4_output_200’);
f3=load(’rk4_output_400’);
f4=load(’rk4_output_800’);
f5=load(’rk4_output_1600’);
len = length(f1(:,1))
j=1
k=1
p=1
m=1
for i=1:1:len
f1(i,1), f2(j,1), f3(k,1),f4(p,1),f5(m,1)
eoc1(i)=log2(abs(abs((f1(i,4))-abs(f2(j,4)))./abs((f2(j,4))-abs(f3(k,4)))))
eoc2(i)=log2(abs((abs(f2(j,4))-abs(f3(k,4)))./(abs(f3(k,4))-abs(f4(p,4)))));
eoc3(i)=log2(abs((f3(k,2)-f4(p,2))./(f4(p,2)-f5(m,2))))
j=j+2;
k=k+4;
p=p+8;
m=m+16;
end
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hold off
g=f1(:,1);
plot(g,eoc1,’b’)
hold on
plot(g,eoc2,’g’)
hold on
plot(g,eoc3,’r’)
xlabel(’Weeks’)
ylabel(’EOC’)
legend(’h=0.3’,’h=0.15’,’h=0.075’)
Figure 5.0
function rkdormand_systems(a, b, N, alpha)
format long
alpha=[22058 1 1]
b=30
a1=0
N=120
m = size(alpha,1);
h = (b-a1)/N;
t(1) = a1;
w(:,1) = alpha;
w1(:,1) = alpha;
for i = 1:N
k1 = h*f(t(i), w(:,i));
k2 = h*f(t(i)+h/5, w(:,i)+(1/5)*k1);
k3 = h*f(t(i)+(3/10)*h, w(:,i)+(3/40)*k1+(9/40)*k2);
k4 = h*f(t(i)+(4/5)*h, w(:,i)+(44/45)*k1-(56/15)*k2+(32/9)*k3);
k5 = h*f(t(i)+(8/9)*h, w(:,i)+(19372/6561)*k1-(25360/2187)*k2
+(64448/6561)*k3-(212/729)*k4);
k6 = h*f(t(i)+h, w(:,i)+(9017/3168)*k1-(355/33)*k2+(46732/5247)*k3+(49/176)*k4
-(5103/18656)*k5);
k7 = h*f(t(i)+h, w(:,i)+(35/384)*k1+(500/1113)*k3+(125/192)*k4
-(2187/6784)*k5+(11/84)*k6);
w(:,i+1) = w(:,i)+ (35/384)*k1 + (500/1113)*k3 + (125/192)*k4 -(2187/6784)*k5
+(11/84)*k6 ;
w1(:,i+1) = w1(:,i) + (5179/57600)*k1 + (7571/16695)*k3+(393/640)*k4
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-(92097/339200)*k5+(187/2100)*k6 +(1/40)*k7;
t(i+1) = t(i) + h;
end
hold on
plot(t,w,’:’)
legend(’S’,’I’,’R’)
hold on
h = (b-a1)/N;
tspan=[0:h:30];
options=odeset(’RelTol’,1e-3,’AbsTol’,1e-4,’NonNegative’,[1 2 3]);
[t1 y1] = ode45(’bombay’,tspan,alpha, options);
plot(t,y1)
e=w(:,N+1)
function bombay =f(t,y)
r =0.000045139 ;
a = 0.5;
bombay(1) =-r*y(1)*y(2);
bombay(2) = r*y(1)*y(2)-a*y(2);
bombay(3) = a*y(2);
bombay = [bombay(1) bombay(2) bombay(3)]’;
Figure 5.1
to = 0;
tf =30;
h=1;
hax=axes;
n=30/h;
yo = [22058 1 0];
tspan=0:5:30;
options=odeset(’RelTol’,1e-3,’AbsTol’,1e-4,’NonNegative’,[1 2 3]);
options =odeset(’OutputFcn’,@odephas2,’OutputSel’,[1 2]);
[t1 y1 stats] = ode45(’bombay’,[to tf],yo, options)
hold on
[t2 y2 stats] = ode45(’bombay’,[to tf],[15000 7058 0], options)
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hold on
[t3 y3 stats] = ode45(’bombay’,[to tf],[12000 10058 0], options)
hold on
[t4 y4 stats] = ode45(’bombay’,[to tf],[10000 12058 0], options)
hold on
[t5 y5 stats] = ode45(’bombay’,[to tf],[18000 4058 0], options)
hold on
[t6 y6 stats] = ode45(’bombay’,[to tf],[6000 16058 0], options)
xlabel(’Susceptible Population’)
ylabel(’Infected Population’)
hold on
q=[11076.94,11076.94]
d=[0,10982.06]
plot(q,d,’color’,’r’)
hold on
line([0 22059],[22059 0]);
plot([0 22059],[22059 0]);
\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%\%
function bombay =f(t,y)
r =0.000045139 ;
a = 0.5;
bombay(1) =-r*y(1)*y(2);
bombay(2) = r*y(1)*y(2)-a*y(2);
bombay(3) = a*y(2);
bombay = [bombay(1) bombay(2) bombay(3)]’;
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